We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$565M
AUM Growth
+$42.1M
Cap. Flow
-$2.06M
Cap. Flow %
-0.36%
Top 10 Hldgs %
37.22%
Holding
341
New
23
Increased
52
Reduced
104
Closed
29

Top Buys

Rank Stock Value
1
MBLY icon
Mobileye
MBLY
+$2.8M
2
APD icon
Air Products & Chemicals
APD
+$2.39M
3
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$2.22M
4
WSO icon
Watsco Inc
WSO
+$1.62M
5
P
Everpure Inc
P
+$1.61M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.56M
2
PEP icon
PepsiCo
PEP
+$1.42M
3
TT icon
Trane Technologies
TT
+$1.18M
4
AVGO icon
Broadcom
AVGO
+$1.17M
5
TSCO icon
Tractor Supply
TSCO
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 36.21%
2 Healthcare 13.53%
3 Consumer Discretionary 10.22%
4 Industrials 8.96%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DV icon
276
DoubleVerify
DV
$2.03B
$9.81K ﹤0.01%
+279
New +$10.4K
KIDS icon
277
OrthoPediatrics
KIDS
$641M
$9.62K ﹤0.01%
330
-486
-60% -$13.6K
VHT icon
278
Vanguard Health Care ETF
VHT
$19B
$9.47K ﹤0.01%
35
– –
RSG icon
279
Republic Services
RSG
$66B
$8.42K ﹤0.01%
44
– –
SDGR icon
280
Schrodinger
SDGR
$1.4B
$8.1K ﹤0.01%
+300
New +$8.39K
DNP icon
281
DNP Select Income Fund
DNP
$4.1B
$8.01K ﹤0.01%
883
-883
-50% -$7.8K
XSOE icon
282
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.09B
$7.87K ﹤0.01%
267
-420
-61% -$12K
NKE icon
283
Nike
NKE
$61.3B
$7.05K ﹤0.01%
75
– –
MS icon
284
Morgan Stanley
MS
$338B
$6.59K ﹤0.01%
70
– –
CMA
285
DELISTED
Comerica
CMA
$6.32K ﹤0.01%
115
– –
CHTR icon
286
Charter Communications
CHTR
$18.9B
$5.81K ﹤0.01%
20
– –
VFC icon
287
VF Corp
VFC
$5.8B
$5.37K ﹤0.01%
350
-250
-42% -$4.02K
XLK icon
288
State Street Technology Select Sector SPDR ETF
XLK
$122B
$5K ﹤0.01%
48
+4
+9% +$405
GE icon
289
GE Aerospace
GE
$381B
$4.74K ﹤0.01%
+34
New +$4.01K
AEHR icon
290
Aehr Test Systems
AEHR
$3.8B
$4.71K ﹤0.01%
380
– –
GTM
291
ZoomInfo Technologies
GTM
$1.19B
$4.01K ﹤0.01%
250
– –
FLNC icon
292
Fluence Energy
FLNC
$2.41B
$3.47K ﹤0.01%
+200
New +$3.66K
ADPT icon
293
Adaptive Biotechnologies
ADPT
$4.08B
$3.21K ﹤0.01%
1,000
– –
IHI icon
294
iShares US Medical Devices ETF
IHI
$3.48B
$2.99K ﹤0.01%
51
+10
+24% +$565
ARWR icon
295
Arrowhead Research
ARWR
$12.6B
$2.86K ﹤0.01%
100
– –
RUM icon
296
RUM Group Inc
RUM
$1.93B
$2.83K ﹤0.01%
350
-105
-23% -$678
DXCM icon
297
DexCom
DXCM
$33.7B
$2.77K ﹤0.01%
20
-394
-95% -$49.5K
MCK icon
298
McKesson
MCK
$105B
$2.69K ﹤0.01%
+5
New +$2.54K
DIS icon
299
Walt Disney
DIS
$179B
$2.08K ﹤0.01%
17
+8
+89% +$836
VNT icon
300
Vontier
VNT
$4.63B
$2K ﹤0.01%
44
-110
-71% -$4.29K
10 11
12
13 14

Similar funds

CGIM
Capital Group Investment Management Raffles Quay, Singapore $585M AUM 31.36% 1-Year Est. Return
TAM
Talos Asset Management New York $585M AUM 204.8% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $586M AUM 15.35% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
FMI
Frec Markets Inc San Francisco, California $587M AUM
PFG
Premier Financial Group Eureka, California $587M AUM 21.88% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return

Arcadia Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Arcadia Investment Management held 341 positions worth $565M, up 8% from $523M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arcadia Investment Management's Q1 2024 filing shows 23 new, 52 increased, 104 reduced and 29 closed positions. Its largest new stake was Dyne Therapeutics: 31,325 shares worth $889K. The largest sale was Bristol-Myers Squibb, an estimated $1.56M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q1 2024 buy was Dyne Therapeutics: 31,325 shares worth $889K.
  • Arcadia Investment Management added most to Mobileye in Q1 2024, an estimated $2.8M increase.
  • Arcadia Investment Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.56M.
  • Arcadia Investment Management fully exited East-West Bancorp in Q1 2024, selling an estimated $737K.
  • Arcadia Investment Management's ten largest holdings make up 37% of its $565M portfolio in Q1 2024.
  • Arcadia Investment Management opened 23 new positions and closed 29 in Q1 2024.
  • Arcadia Investment Management's portfolio value rose 8% quarter-over-quarter to $565M.

Based on Arcadia Investment Management's 13F filing for Q1 2024, filed 23 Apr 2024.